Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome

European Journal of Preventive Cardiology

Volumn 11, Issue 2, 2004, Pages 144-148

  ã… aboviㄍ, Miã…¡o ^a   Lavre, Simona ^a   Keber, Irena ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

cardiovascular metabolic syndrome; cardiovascular risk; diet; fibre; wheat fibre

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DYSMETABOLIC CARDIOVASCULAR SYNDROME; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HIGH FIBER DIET; HUMAN; INSULIN BLOOD LEVEL; MALE; METABOLISM; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION; WHEAT;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PROTEINS; CHOLESTEROL; DIETARY FIBER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYSACCHARIDES; TRIGLYCERIDES; WEIGHT LOSS;

EID: 2342536387     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000124213.21584.75     Document Type: Article

References (20)

1. Fagan TC, Deedwania PC. The cardiovascular dysmetabolic syndrome. Am J Met 1998; 105(1A):77S–82S.
2. Lindahl B, Asplund K, Hallmans G. High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The Northern Sweeden MONICA Population Study. J Intern Med 1993; 234: 263–270.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA 2002; 287: 356–359.
4. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952–957.
5. Smiley T, Oh P, Shane LG. Relationship of insulin resistance measured by reliable indexes to coronary artery disease risk factors and outcomes: a systematic review. Can J Cardiol 2001; 17: 797–805.
6. Haffner SM. Epidemiology of insulin resistance and its relations to coronary artery disease. Am J Cardiol 1999; 84: 11J–14J.
7. The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: baseline characteristics of the randomised cohort. Diabetes Care 2000; 23: 1619–1629.
8. Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE, et al. Whole grain consumption and risk of coronary heart disease: results from the Nurse Health Study. Am J Clin Nutr 1999; 70: 412–419.
9. Wolk A, Manson JE, Stampler MJ, Colditz GA, Hu FB, Speizer FE, et al. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 1999; 281: 1998–2004.
10. Ascherio A, Rimm EB, Hernan MA, Giovannucci EL, Kawachi MD, Stamfer MJ, et al. Intake of potassium, magnesium, calcium and fiber and risk of stroke among US men. Circulation 1998; 98: 1198–1204.
11. Groop P, Aro A, Stenman S, Groop L. Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1993; 58: 513–518.
12. Gatenby S, Ellis PR, Morgan LM, Judd PA. Effect of partially depolymerized guar gum on acute metabolic variables in patients with non-insulin-dependent diabetes. Diabetic Med 1996; 13: 358–364.
13. Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. Beneficial effects of high dietary fibre intake in patients with type II diabetes mellitus. N Engl J Med 2000; 342: 1392–1398.
14. Eriksson KF, Lindgärde F. Prevention of type II (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmö feasibility study. Diabetologia 1991; 34: 891–898.
15. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 1997; 20: 537–544.
16. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. for the Finnish Diabetes Prevention Study Group. N Engl J Med 2001; 344: 1343–1350.
17. Reddy BS. Role of dietary fiber in colon cancer: an overview. Am J Med 1999; 106(1A):16S–19S.
18. Laws A, Reaven GM. Insulin resistance and risk factors for coronary heart disease. Baillièrés Clin Endocrinol Metab 1993; 7: 1063–1078.
19. Petrie JR, Ueada S, Webb DJ, Elliot HL, Connell JM. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996; 93: 1331–1333.
20. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympatoadrenal system. N Eng J Med 1996; 334: 374–381.